People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SutroVax, Inc. | — | Biotechnology | Series D+ | $205.9M | $4.5B | 2017 |
| Therini Bio, Inc. | — | Biotechnology | Series C | $84.2M | $1.1B | 2019 |
| PanOptica, Inc. | — | Biotechnology | Series C | $57.3M | $1.7B | 2014 |
| MindImmune Therapeutics, Inc. | — | Pharmaceuticals | Series B | $21.3M | $61.2M | 2022 |
| Reservoir Neuroscience, Inc. | — | Biotechnology | Seed | $6.0M | $14.4M | 2021 |
Tracy Saxton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tracy Saxton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Ross | 1 | 18 |
| Patrick Heron | 1 | 11 |
| Patrick Enright | 1 | 10 |
| Christopher O'Donnell | 1 | 8 |
| David Guyer | 1 | 8 |
| Robert Nelson | 1 | 7 |
| Patrick J. Heron | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Lutz Giebel | 1 | 6 |
| Kurt Von Emster | 1 | 6 |
| ABBIE CELNIKER | 1 | 6 |
| Bruce Peacock | 1 | 5 |
| Colin Goddard | 1 | 5 |
| Thomas Dyrberg | 1 | 5 |
| Kevin Starr | 1 | 5 |
| Daniel Burgess | 1 | 4 |
| William J. Newell | 1 | 3 |
| Daniel D. Burgess | 1 | 3 |
| Elaine Sun | 1 | 3 |
| Ashish Khanna | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.